151 related articles for article (PubMed ID: 20414754)
1. Nuclear grading versus Gleason grading in small samples containing prostate cancer: a tissue microarray study.
Wittschieber D; Köllermann J; Schlomm T; Sauter G; Erbersdobler A
Pathol Oncol Res; 2010 Dec; 16(4):479-84. PubMed ID: 20414754
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
3. A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores.
Leyh-Bannurah SR; Trudel D; Latour M; Zaffuto E; Grosset AA; Tam C; Ouellet V; Graefen M; Budäus L; Aprikian AG; Lacombe L; Fleshner NE; Gleave ME; Mes-Masson AM; Saad F; Karakiewicz PI
Pathol Oncol Res; 2019 Jul; 25(3):979-986. PubMed ID: 29623528
[TBL] [Abstract][Full Text] [Related]
4. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
5. Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence.
Corcoran NM; Hong MK; Casey RG; Hurtado-Coll A; Peters J; Harewood L; Goldenberg SL; Hovens CM; Costello AJ; Gleave ME
BJU Int; 2011 Oct; 108(8 Pt 2):E202-10. PubMed ID: 21443656
[TBL] [Abstract][Full Text] [Related]
6. Should we replace the Gleason score with the amount of high-grade prostate cancer?
Vis AN; Roemeling S; Kranse R; Schröder FH; van der Kwast TH
Eur Urol; 2007 Apr; 51(4):931-9. PubMed ID: 16935413
[TBL] [Abstract][Full Text] [Related]
7. Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis.
Harnden P; Shelley MD; Coles B; Staffurth J; Mason MD
Lancet Oncol; 2007 May; 8(5):411-9. PubMed ID: 17466898
[TBL] [Abstract][Full Text] [Related]
8. Correlations among prostatic-specific antigen, Gleason score, staging and grading in patients after radical prostatectomy.
Szymanowski J; Dudek P; Ratajski J; Wysocki M
BJU Int; 2002 Apr; 89(6):612-3. PubMed ID: 11942975
[TBL] [Abstract][Full Text] [Related]
9. Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer.
Huang JG; Pedersen J; Hong MK; Harewood LM; Peters J; Costello AJ; Hovens CM; Corcoran NM
BJU Int; 2013 May; 111(6):921-7. PubMed ID: 23350712
[TBL] [Abstract][Full Text] [Related]
10. Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy.
Guimaraes MS; Quintal MM; Meirelles LR; Magna LA; Ferreira U; Billis A
Int Braz J Urol; 2008; 34(1):23-9. PubMed ID: 18341718
[TBL] [Abstract][Full Text] [Related]
11. Gleason inflation 1998-2011: a registry study of 97,168 men.
Danneman D; Drevin L; Robinson D; Stattin P; Egevad L
BJU Int; 2015 Feb; 115(2):248-55. PubMed ID: 24552193
[TBL] [Abstract][Full Text] [Related]
12. Correlation between Gleason score of needle biopsy and radical prostatectomy tissue.
Cecchi M; Minervini R; Sepich CA; Ippolito C; Pagni GL; Summonti D; Di Benedetto A; Fiorentini L
Int Urol Nephrol; 1998; 30(5):575-80. PubMed ID: 9934800
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Gleason scores between needle-core biopsy and radical prostatectomy specimens in patients with prostate cancer.
Hsieh TF; Chang CH; Chen WC; Chou CL; Chen CC; Wu HC
J Chin Med Assoc; 2005 Apr; 68(4):167-71. PubMed ID: 15850066
[TBL] [Abstract][Full Text] [Related]
14. Prognostic influence of the third Gleason grade in prostatectomy specimens.
Cedeño Díaz OM; Fernández Aceñero MJ; Alvarez Fernández E
Urol Oncol; 2012; 30(4):386-90. PubMed ID: 21292510
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
[TBL] [Abstract][Full Text] [Related]
16. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
17. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA
Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051
[TBL] [Abstract][Full Text] [Related]
18. Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.
Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Habuchi T; Ohyama C; Arai Y
BJU Int; 2013 May; 111(6):914-20. PubMed ID: 23320782
[TBL] [Abstract][Full Text] [Related]
19. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
20. Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens.
Whittemore DE; Hick EJ; Carter MR; Moul JW; Miranda-Sousa AJ; Sexton WJ
J Urol; 2008 Feb; 179(2):516-22; discussion 522. PubMed ID: 18076949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
